ABOUT THIS EPISODE
Can a single drop of blood tell you whether you'll develop pancreatic cancer — before any symptoms appear? Prof. Eleonora Macchia is working to make that a reality. This week on SciLux, we dig into biosensors, the science of proteins, and the surprising path from organic transistors to clinical trials.
What you'll learn:
- Why the proteome is medicine's great unknown
- How current tests (ELISA, lateral flow) fail at ultra-low concentrations, and what SiMoT technology does differently
- What it actually means to detect a single molecule in a patient's blood sample
- Why AI in diagnostics is only as good as the physicist standing behind the data
- How chemometrics – AI's "old-fashioned cousin" – underpins the whole approach
Key Themes:
- Frontier research and ERC funding advocacy
- Single-molecule biosensing and the SiMoT technology
- Preventive medicine vs. reactive diagnosis
- AI, chemometrics, and data quality
- Circular health and multidisciplinary science
- Gender balance in research careers
Guest: Prof. Eleonora Macchia, University of Bari & Åbo Akademi University
USEFUL LINKS
More about Prof. Eleonora Macchia: https://scholar.google.com/citations?user=tj6pKhAAAAAJ&hl=en
ERC Ambassadors: https://erc.europa.eu/news-events/news/network-ambassadors-erc-expands
More about SiMoT: https://theanalyticalscientist.com/issues/2024/articles/apr/the-single-molecule-sensor
University of Bari: https://www.uniba.it/en
Åbo Akademi University: https://www.abo.fi/en/
jingle track (get it) provided by mobygratis.
